Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00139152 · ClinicalTrials.gov registry record · Phase 4
Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair
A Phase 4 study, sponsored by Creighton University.
- Completed
- Registry status
- Phase 4
- Development phase
- 65
- Enrollment target
NCT00139152 is a Phase 4 study that has completed, run by Creighton University. The registered enrollment target is 65 participants.
The verdict
NCT00139152, a Phase 4 study, has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 65 participants
- Enrollment target
Study Summary
The purpose of this study is to study the effects of Xolair using non-invasive techniques from the expired gas of patients with moderate to severe allergic asthma.
Interventions
- DRUG Placebo
- DRUG Xolair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00139152
The ClinicalTrials.gov registry entry for NCT00139152 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00139152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00139152 about?
NCT00139152 is a clinical study titled "Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair". The purpose of this study is to study the effects of Xolair using non-invasive techniques from the expired gas of patients with moderate to severe allergic asthma.
What is the current status of trial NCT00139152?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 65 participants. The study started on 2005-09. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00139152?
The interventions under investigation include: Placebo (DRUG), Xolair (DRUG).
Who is sponsoring clinical trial NCT00139152?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.